prodchem
Aug 21, 2026
The U.S. chemical industry is entering 2026 with a much weaker growth outlook than it achieved the previous year. According to the American Chemistry Council (ACC), U.S. chemical industry output is expected to grow only 0.3% in 2026, compared with 0.7% growth recorded in 2025. The forecast points to another year of limited expansion before a projected 2.3% rebound in 2027.
For chemical manufacturers, suppliers, traders and procurement teams, the numbers provide a useful benchmark for understanding where the U.S. chemical cycle currently stands.
The bigger question is whether 2026 represents a temporary slowdown or another stage of a longer period of subdued industrial growth.
The U.S. chemical industry recorded approximately 0.7% growth in 2025.
While positive, that performance was hardly a strong expansion year.
Chemical producers continued to face:
Uneven industrial demand
Global oversupply
High operating costs
Import competition
Weakness across some downstream markets
The 2025 result therefore established a relatively low baseline for the industry's 2026 outlook.
The ACC's 0.3% growth forecast for 2026 represents a significant moderation from the previous year's performance.
The difference may appear small numerically.
But for a capital-intensive industry, even a fraction of a percentage point can matter.
Chemical companies operate large production assets where profitability depends heavily on:
Capacity utilization
Pricing
Feedstock costs
Energy costs
Downstream demand
When demand grows slowly, companies can struggle to achieve the utilization rates required to support margins.
The more interesting part of the ACC outlook is what comes next.
The organization expects U.S. chemical industry growth to accelerate to approximately 2.3% in 2027.
That would represent a substantial improvement from:
0.7% in 2025
0.3% in 2026
2.3% projected in 2027
This creates a potential three-stage cycle: modest growth → slowdown → recovery.
A weak 2026 does not necessarily mean the chemical industry is entering a prolonged contraction.
Instead, several factors could create the conditions for a later recovery.
These include:
Lower interest rates
Stronger manufacturing activity
Improved consumer demand
Inventory normalization
Better export conditions
Stabilization in downstream industries
If these factors develop as expected, chemical demand could strengthen during 2027.
Commodity and petrochemical producers are particularly sensitive to changes in global capacity.
New production capacity in Asia and the Middle East has increased competition in several chemical value chains.
This can pressure:
Ethylene
Propylene
Polyethylene
Polypropylene
Aromatics
Basic intermediates
Even if U.S. demand improves, global oversupply can prevent producers from fully converting volume growth into higher margins.
Specialty chemical companies may experience somewhat different conditions.
Their businesses often depend on application-specific demand from:
Automotive
Electronics
Construction
Agriculture
Pharmaceuticals
Personal care
These markets can respond differently to broader economic conditions.
A weak commodity-chemical environment therefore does not automatically translate into equally weak specialty-chemical performance.
The chemical industry sits near the beginning of numerous manufacturing supply chains.
That makes chemical demand closely connected to industrial production.
When factories produce more:
Chemical consumption increases.
When manufacturing slows:
Chemical demand weakens.
The 2026 forecast therefore provides a useful proxy for the broader health of U.S. industrial activity.
U.S. chemical producers retain important feedstock advantages in several markets because of access to relatively competitive natural gas and NGL supplies.
However, feedstock advantage alone cannot overcome weak demand.
A producer can have attractive production economics and still face margin pressure when selling prices fall because of excess global supply.
This is why procurement teams should monitor both:
Feedstock economics
and
Demand conditions.
U.S. chemical producers also compete with imported materials.
Lower-cost overseas production can pressure domestic pricing, particularly in commodity segments.
For buyers, this can create opportunities to compare:
Domestic suppliers
Asian suppliers
Middle Eastern producers
European producers
Regional distributors
A low-growth domestic market can therefore still produce active international trade flows.
One of the most important indicators to watch during 2026 will be capacity utilization.
If demand grows only 0.3%, producers may delay:
New capacity
Expansion projects
Plant debottlenecking
Large capital investments
At the same time, companies with higher-cost facilities may consider:
Temporary shutdowns
Permanent closures
Asset sales
Restructuring
This could eventually help rebalance supply and demand.
Chemical companies' investment decisions can provide an early indication of management expectations.
If companies believe the 2027 recovery is credible, they may continue investing in:
Advanced materials
Specialty chemicals
Battery materials
Recycling
Low-carbon technologies
Automation
Domestic manufacturing
If capital spending declines sharply, it could signal that companies remain cautious about the recovery.
Moving from 0.3% growth in 2026 to 2.3% in 2027 would represent a substantial acceleration.
For chemical manufacturers, stronger demand could improve:
Plant utilization
Pricing power
Margins
Inventory turnover
Capital investment
The recovery would also benefit chemical distributors and logistics providers if higher production translates into greater shipment volumes.
Procurement managers should use the 2026 slowdown as an opportunity to reassess supplier strategies.
Key indicators include:
Supplier capacity utilization
Contract pricing
Feedstock costs
Import competition
Plant shutdowns
Inventory levels
New capacity
Financial health
A slow-growth environment can provide buyers with greater negotiating leverage.
For traders, the most important signals may include:
Regional price spreads
Import arbitrage
Plant outages
Capacity closures
Feedstock movements
Inventory changes
A weak U.S. demand environment can create opportunities when regional supply-demand balances diverge.
Investors should focus on whether the 2026 slowdown is already reflected in company valuations.
Important indicators include:
Is demand actually weakening?
Are producers maintaining profitability despite low growth?
Are facilities operating efficiently?
Are companies preparing for 2027?
Are weaker assets becoming acquisition targets?
Are companies removing structurally uncompetitive capacity?
The ACC forecast provides a useful three-year benchmark.
Year | U.S. Chemical Industry Growth |
|---|---|
2025 | 0.7% |
2026 Forecast | 0.3% |
2027 Forecast | 2.3% |
The pattern suggests that 2026 could represent a low point before a stronger recovery.
But the recovery remains dependent on broader economic and industrial conditions.
The ACC's forecast paints a mixed picture for U.S. chemicals.
The industry is not expected to contract in 2026, but 0.3% growth represents a very weak expansion compared with the 0.7% achieved in 2025.
The more important signal is the projected 2.3% growth in 2027.
If that rebound materializes, companies that maintain financial discipline through the 2026 slowdown could enter the recovery with stronger competitive positions.
For chemical manufacturers, the priority will be protecting margins and controlling costs.
For procurement teams, the environment could create opportunities to negotiate supply agreements and diversify sourcing.
For traders, regional imbalances may become more important than overall U.S. growth.
The central intelligence question is therefore not simply whether the U.S. chemical industry grows in 2026.
It is whether 2026 becomes the trough from which the industry begins its next meaningful expansion cycle in 2027.
The ACC forecasts 0.3% U.S. chemical industry growth in 2026, below the 0.7% recorded in 2025.
The industry is projected to accelerate to approximately 2.3% growth in 2027.
The 2026 forecast points to a year of subdued demand rather than outright contraction.
Global chemical oversupply could continue pressuring commodity producers.
Specialty chemicals may experience different demand conditions depending on their end markets.
Capacity utilization and plant closures will be important indicators during the slowdown.
Capital spending could reveal whether companies are positioning for the expected 2027 recovery.
Procurement teams may gain negotiating leverage in a low-growth market.
Chemical traders should monitor regional price differences, imports and capacity changes.
The key question is whether 2026 represents the bottom of the current U.S. chemical cycle.
Featured Product
Found this useful?
Continue Reading
The April 2026 chemical incident in Institute, West Virginia continues to draw attention from chemical safety trade associations. Its focus on decommissioning procedures and hazard review protocols offers important lessons for companies managing aging or retired chemical assets.
Khartis plans to launch its first clinical trial for an oral IGF-1R inhibitor in the first quarter of 2027. The program will advance alongside three additional preclinical immunology programs, creating new implications for pharmaceutical sourcing and development supply chains.
Khartis brings former XinThera leaders back together after Gilead’s 2023 acquisition of the company. The move highlights how experienced small-molecule research teams can become a foundation for new pharmaceutical ventures.
